Summary
The startup, which has received funding from investors including Radical Ventures and Sofinnova Partners, aims to bridge the gap between computation and biology by providing AI-powered solutions for biopharma, biotechs, and life science companies. The company's models will be used for tasks such as protein design and biological system design.
Key Points
The startup has received $50 million in funding from investors including Radical Ventures and Sofinnova Partners.
The company's approach involves either giving its partners direct access to its AI-powered models or supporting their discovery programs via project-based partnerships.
The startup aims to bridge the gap between computation and biology by providing AI-powered solutions for biopharma, biotechs, and life science companies.
Why It Matters
This funding sets the stage for the startup to continue scaling its model, teams, and commercial traction while enabling biopharma, biotechs, and life science companies to utilize AI-powered models for discovery.
Author
Paul Sawers